Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:7 Issue:3 Number:23 ISSN#:2563-5476
ACE Report #10119
Ace Report Cover Arthroplasty

AAOS2018: ciNPWT vs occlusive dressing for reducing wound complications in revision THA and TKA

How to Cite

OrthoEvidence. AAOS2018: ciNPWT vs occlusive dressing for reducing wound complications in revision THA and TKA. ACE Report. 2018;7(3):23. Available from: https://myorthoevidene.com/AceReport/Report/10119

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Use of Closed Incisional Negative Pressure Wound Therapy after Revision Total Hip and Knee Arthroplasty in Patients at High Risk for Infection: A Prospective, Randomized Clinical Trial

Contributing Authors: WK Barsoum AK Klika JM Newman MBP Siqueira G Yakubek CA Higuera Rueda

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


160 patients scheduled for revision total hip or knee arthroplasty with at least one risk factor for postoperative wound complication were randomized to postoperative management with either closed incisional negative pressure wound therapy (ciNPWT) or a silver-impregnated occlusive dressing. Patients were assessed for the incidences of wound complication, readmission, and reoperation within the f...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.